The Department of Defense’s Multidrug-resistant Organism Repository and Surveillance Network has identified the first bacteria in the U.S. with a gene that confers resistance to colistin, an antibiotic used to treat multidrug-resistant infections, the Department of Health and Human Services announced yesterday. The mcr-1 gene, which is capable of spreading antibiotic resistance between different species of bacteria, was found in E coli bacteria in a patient treated in an outpatient military facility in Pennsylvania, as well as in a pig intestine. The gene was first discovered last November in China and also has been detected in Europe and Canada. The Centers for Disease Control and Prevention is working with DoD, the Pennsylvania Department of Health and others to determine whether any close contacts of the patient, including health care contacts, may have been at risk for transmitting the bacteria. The Department of Agriculture also is working to determine the pig’s farm of origin. 

Related News Articles

Headline
More than 880,000 physicians were certified by the American Board of Medical Specialties in 2017, about 20,000 more than in 2016, according to the board’…
Headline
The Centers for Medicare & Medicaid Services has identified the first clinicians eligible to participate in 2018 advanced alternative payment models, based…
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
In a letter this week, the AHA again urged the Centers for Medicare & Medicaid Services to take specific actions to address and prevent the serious…
Headline
AHA has activated The Care Fund to provide support to hospital employees in Puerto Rico who experienced significant property loss or damage from any natural…
Headline
The AHA today urged members of the U.S. Senate “to protect our patients and find ways to maintain coverage for as many Americans as possible” by…